Loading ...The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and Avaglim…
Popular
type 2 diabetes type 1 diabetes Diabetes Complications diabetes research diabetes management managing diabetes JDRF diabetes support american diabetes association Diabetes Community women's health obesity type 2 diabetes risk children's health type 2 diabetes prevention kids with diabetes diabetes type 2 diabetes treatment insulin diabetes treatment obesity epidemic insulin resistance juvenile diabetes children with diabetes Tanya Zuckerbrot